Co-Authors
This is a "connection" page, showing publications co-authored by THOMAS LLOYD and AZIZ SHAIBANI.
Connection Strength
0.100
-
Safety and efficacy of arimoclomol for inclusion body myositis: a multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2023 10; 22(10):900-911.
Score: 0.054
-
Efficacy and Safety of Bimagrumab in Sporadic Inclusion Body Myositis: Long-term Extension of RESILIENT. Neurology. 2021 03 23; 96(12):e1595-e1607.
Score: 0.045